National Vision Holdings Inc. Common Stock (EYE)
Stock · NASDAQ · Health Care
$17.43as of 10/16/2026
Price chart
EYE Signal Track Record
How signals performed across all stocks →What EYE's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 29 | -2.4% | 41% | September 18, 2026 |
| Bollinger Band Breakdown | 23 | +2.5% | 52% | September 15, 2026 |
| Bollinger Band Breakout | 23 | +1.9% | 70% | July 28, 2026 |
| 200-Day Moving Average TouchActive now | 11 | -1.7% | 45% | March 31, 2026 |
| Any 20-session window (baseline) | -0.1% | 50% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About EYE
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company offers eyeglasses and contact lenses, and optical accessory products; and provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, Vista Optical military, and DiscountContacts.com. It also offers health maintenance organization and optometric services. In additio…
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- Employees
- 13,138
- Website
- www.nationalvision.com/
Fundamentals
- 1-day range
- $17.25$18.01
- Market cap
- $1.80B
- P/E (trailing)
- 27.65
- P/E (forward)
- 14.62
- EPS (trailing)
- $0.62
- Dividend yield
- —
- Beta
- 0.95
- Avg. volume
- 2.10M
How National Vision Holdings Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 4, 2026 · via SEC EDGAR / Finnhub
Forecasts
11 analyst ratings
National Vision Holdings Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- EYENational Vision Holdings Inc. Common Stock$17.43▼ 1.30%Market cap $1.80BP/E 27.65$14.75$30.02
- STAASTAAR Surgical Company Common Stock$21.27▼ 4.45%Market cap $1.15BP/E 288.93$15.59$35.87
- WRBYWarby Parker Inc. Class A Common Stock$23.34▼ 5.08%Market cap $3.31BP/E 365.43$14.96$31
- RXSTRxSight Inc. Common Stock$4.51▼ 3.43%Market cap $251.69MP/E —$4.4$13.22
- LUCYInnovative Eyewear Inc. Common Stock$0.79▼ 6.29%Market cap $6.19MP/E —$0.65$2.05
- LUCYWInnovative Eyewear Inc. Series A Warrants 8/16/27$0.0251▼ 10.36%Market cap $556.8KP/E —$0.0251$0.152
- BLCOBausch + Lomb Corporation Common Shares$16.49▼ 1.02%Market cap $5.84BP/E —$14.44$18.92
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| EYE National Vision Holdings Inc. Common Stock | $1.80B | 27.65 | $17.43 | ▼ 1.30% | $14.75$30.02 |
| STAA STAAR Surgical Company Common Stock | $1.15B | 288.93 | $21.27 | ▼ 4.45% | $15.59$35.87 |
| WRBY Warby Parker Inc. Class A Common Stock | $3.31B | 365.43 | $23.34 | ▼ 5.08% | $14.96$31 |
| RXST RxSight Inc. Common Stock | $251.69M | — | $4.51 | ▼ 3.43% | $4.4$13.22 |
| LUCY Innovative Eyewear Inc. Common Stock | $6.19M | — | $0.79 | ▼ 6.29% | $0.65$2.05 |
| LUCYW Innovative Eyewear Inc. Series A Warrants 8/16/27 | $556.8K | — | $0.0251 | ▼ 10.36% | $0.0251$0.152 |
| BLCO Bausch + Lomb Corporation Common Shares | $5.84B | — | $16.49 | ▼ 1.02% | $14.44$18.92 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- EYE or CL: Which Is the Better Value Stock Right Now?Yahoo · 9/28/2026
- Exclusive: National Vision CEO on traffic, ticket growth and the digital shiftYahoo · 9/23/2026
- National Vision Holdings: Valuation Outshines Room For Improvement In FundamentalsSeekingAlpha · 9/17/2026
- Should Investors Add EYE Stock to Their Portfolios Now?Yahoo · 9/15/2026
- Why Is National Vision (EYE) Down 10.1% Since Last Earnings Report?Yahoo · 9/11/2026
Insider Activity
Insider Actions →- Cutler David G · September 8, 2026 · Option Exercise13.0K
- Cutler David G · September 8, 2026 · Tax Withholding5.1K @ $17
- Moeddel Ana · September 2, 2026 · Option Exercise11.4K
- Moeddel Ana · September 2, 2026 · Tax Withholding3.1K @ $16.82
- Wilkes Alexander · August 19, 2026 · Option Exercise61.8K
- Wilkes Alexander · August 19, 2026 · Tax Withholding29.9K @ $18.92
- Wilkes Alexander · July 31, 2026 · Option Exercise13.8K
- Wilkes Alexander · July 31, 2026 · Tax Withholding6.7K @ $22.04
- Banner Mark · July 8, 2026 · Option Exercise11.7K
- Banner Mark · July 8, 2026 · Tax Withholding5.0K @ $19.41
- McGrann James M. · June 17, 2026 · Grant11.3K
- Caitlin Zulla · June 17, 2026 · Grant16.3K
- OFarrell Susan C · June 17, 2026 · Grant14.6K
- Kelman Naomi · June 17, 2026 · Grant11.3K
- Johnson Susan S · June 17, 2026 · Grant11.3K
Institutional Ownership
March 31, 2026
- Total shares held
- 89.56M
- Total value held
- $2.30B
- Institutional holders
- 248
- Unknown11.54M
- Unknown5.50M
- Unknown4.23M
- Unknown3.47M
- Unknown3.44M
- Unknown3.22M
- Unknown3.18M
- Unknown3.06M
- Unknown2.50M
- Unknown2.41M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
National Vision Launches 2026-2027 Scholarship Program
National Vision announced a scholarship program for the 2026-2027 academic year. The program aims to support students in fields related to vision care and technology, balancing innovation with human connection. The initiative highlights the company's focus on community engagement and future talent development. It may strengthen brand perception among consumers and prospects.
National Vision Launches 2026-2027 Scholarship Program. National Vision announced a scholarship program for the 2026-2027 academic year. The program aims to support students in fields related to vision care and technology, balancing innovation with human connection. The initiative highlights the company's focus on community engagement and future talent development. It may strengthen brand perception among consumers and prospects.